Sun Pharma wins legal battle over Pantocid's name; uses and side effects of proton pump inhibitors explained

Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the ...
Medscape

Proton Pump Inhibitors Under Scrutiny: How Real Is the Risk?

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
News Medical

Long-term use of proton pump inhibitors associated with increased risk of dementia

In a recent study published in Neurology, researchers determine whether the current and cumulative use of prescription proton pump inhibitors (PPIs) increases the risk of incident dementia. Study: ...
Medscape

Are IV Proton Pump Inhibitors Overused in Upper GI Bleeding?

Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...
ascopubs.org

Proton pump inhibitors and the risk of adverse renal events and all-cause mortality in cancer patients receiving immune checkpoint inhibitors.

Accelerating phase 2 clinical development with real-world data (RWD): An external control arm (ECA) pilot in HER2-positive (HER2+) metastatic breast cancer (mBC). This is an ASCO Meeting Abstract from ...
News Medical

Study challenges link between proton pump inhibitors and kidney disease risk

A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ...
Dagens.com on MSN

Doctor warns long-term use of this medication could be harmful

According to LADbible, omeprazole, a proton pump inhibitor (PPI), is commonly prescribed to treat heartburn and conditions such as gastro-oesophageal reflux disease (GORD). Figures cited in the report ...
ascopubs.org

Five-year survival outcomes in NSCLC patients with concurrent GERD on proton pump inhibitors receiving pembrolizumab or nivolumab: A global study.

Impact of gut microbiota (GM) and antibiotic (ATB) use on immunotherapy efficacy in patients with lung cancer (LC): Preliminary results from a prospective trial. This is an ASCO Meeting Abstract from ...